1. Home
  2. Search Clinical Trials
Search

Filters

Clear All
  • 49
  • 60
  • 6
  • 3
  • 498

Phase

  • 18
  • 15
  • 3
  • 15
  • 6
  • 15
  • 2
  • 439
  • 582
  • 229
  • 606
  • 10
  • 56
  • 27
  • 1
  • 615

Found 616 results

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

test duplicate sync536

E
Edward Stadtmauer
All genders
test duplicate sync
Learn More

Like Milk? Join Our Study!

All genders
Testing 123
Learn More

Letermovir Prophylaxis for Cytomegalovirus in Pediatric Hematopoietic Cell Transplantation

2 years - 18 years
All genders
Phase 3
This phase III trial determines whether taking prophylactic letermovir will reduce the likelihood of infection with cytomegalovirus (CMV) in children and adolescents after stem cell transplant. The treatments used to prepare for HCT reduce the body's natural infection-fighting ability and increase the likelihood of an infection with a virus called …
Learn More

A Phase 3, Prospective, Open-label, Uncontrolled, Multicenter Study onEfficacy and Safety of Prophylaxis with rVWF in Children Diagnosed With Severe von Willebrand disease

All genders
Phase 3
What is the purpose of this study?The main aim of the study is to evaluate the effectiveness of prophylaxis with recombinant von Willebrand factor (rVWF) in children. This study will enroll those participants who have been previously treated with VWF product or with a plasma-derived VWF (pdVWF) product.  
Learn More

A PHASE III, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, TREAT-THROUGH STUDY TO ASSESS THE EFFICACY AND SAFETY OF INDUCTION AND MAINTENANCE THERAPY WITH RO7790121 IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE

18 years - 75 years
All genders
Phase 3
The purpose of this study is to assess the efficacy and safety of RO7790121 (formerly PF-06480605 and RVT-3101) in patients with moderately to severely active Crohn's disease (CD). RO7790121 is a fully human neutralizing immunoglobulin G monoclonal antibody (mAb) against tumor necrosis factor-like ligand 1A (TL1A). TL1A plays a central …
Learn More

Transoral Incisionless Fundoplication Database Repository (TIF) (TIF)

All genders
Observational
Collect data on individuals who have a transoral incisionless fundoplication (TIF) performed by physicians at Indiana University for the treatment of gastroesophageal reflux disease.
Learn More
Online study
611 - 616 of 616